sjb71, hope this helps as well.
As part of the Bell Potter review, they have estimated a cost per patient US$85,000, hence the cost of the trial between US$24m and US$26m, with patients likely to support some costs during the clinical trial process..at june 30 OSL had approx. AU$13.3m cash at hand.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.075(6.10%) |
Mkt cap ! $16.35M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $45.47K | 37.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16450 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 585 | 1 |
View Market Depth
| Last trade - 14.02pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |